ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks, Big ...

This unusual recipe transforms potatoes into transparent crisps—also known as glass chips. By baking, extracting potato stock, turning it into a gel, and slowly drying it, the result is delicate, ...

Hall of Fame quarterback Dan Marino recently revealed that he was diagnosed with metabolic dysfunction-associated steatohepatitis, or MASH. The Miami Dolphins legend said the discovery came years ago ...

Donald Trump suffers double legal blow within hours Massive WWII bomb forces overnight evacuation of 6,000 residents from homes Unplug These Devices from Extension Cords Immediately, an Electrician ...

The brand first made the announcement on social media Thursday. Look out pumpkin spice, another fall favorite flavor is returning to the menu at Starbucks this season, and you don't need to bob for ...

Fall is in the air at Starbucks, and while the coffee chain has already unveiled its fall menu, the chain says Michigan customers will have another fall-inspired drink to look forward to in October.

The coffee giant announced that it is bringing back Apple Crisp for a limited time, starting Oct. 14 Starbucks Starbucks is bringing back its Apple Crisp flavor for fall 2025 The Iced Apple Crisp ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...

Roche targets liver disease treatments with acquisition Deal includes $14.50 a share, potential milestone payments up to $6.00 a share Roche flags potential to treat obesity-related conditions The ...

FRANKFURT (Reuters) - Roche has agreed to buy U.S. biotech firm 89bio for up to $3.5 billion, joining a race to offer new liver disease treatments that complement an intense push in the area of weight ...

NVIDIA Corp. will invest $5 billion in rival Intel Corp. to jointly develop custom processing units. The partnership combines Intel's CPU experience with NVIDIA's specialized graphics chips for AI.